Search Menu

Medicenna Therapeutics Corp.
TSX: MDNA    

Delayed Quote:


Medicenna Therapeutics Corp. is a clinical-stage immunotherapy company developing a family of novel, proprietary therapeutic cytokines called Superkines™. Superkines™ are powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines™ can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines™ ("ECs"). EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates ("ADCs").
Address: Suite 200, 1920 Yonge Street, Toronto, Ontario, Canada M4S 3E2
Phone: (604) 671-6673
Email: fmerchant@medicenna.com
Web: www.medicenna.com
 



Search by Symbol

  Canada   US  


Top